In a new phase of long-term strategies, businesses can consider a metrics-based approach, lobby legislators and local officials to rely on evidence, provide employees and customers with predictability around mask-wearing, and protect health and business operations.
The researchers used data from 185 countries to estimate that vaccines prevented 4.2 million COVID-19 deaths in India, 1.9 million in the United States, 1 million in Brazil, 631,000 in France and 507,000 in the United Kingdom.
After more than two years of navigating the pandemic much like their K-12 counterparts, directors of child care facilities are hoping parents will take advantage of the new vaccines to protect their children and those around them.
Indianapolis Public Schools has spent around 10% of its $213.5 million in federal COVID-19 funding to date. That figure is low compared to other districts in Indiana and across the country, but IPS officials are preparing to spend the full allocation.
While most carriers are enjoying bumper sales as customers flood back following the lifting of COVID curbs, taking leisure trips and catching up with friends and family, there are doubts about how long the surge will continue as high fuel prices push airlines to hike fares.
The FDA also authorized Moderna’s vaccine for school-aged children and teens. Pfizer’s shots had been the only option for those ages.
An advisory panel for the Food and Drug Administration gave a thumbs-up Wednesday to vaccines from Moderna and Pfizer for children under 5. It’s the only age group not yet eligible for vaccination against the coronavirus.
The SBA’s Office of the Inspector General has estimated that at least $80 billion distributed from the $400 billion Economic Injury Disaster Loan program could have been fraudulent, much of it in scams using stolen identities.
In hospitals across the country, physicians are adjusting protocols that for decades reflected a predictable cycle of illnesses that would come and go when schools closed or the weather changed.
The Food and Drug Administration posted its analysis of the Pfizer shot ahead of a Wednesday meeting where outside experts will vote on whether the shots are ready for the nation’s 18 million babies, toddlers and preschoolers.
A senior administration official said the Centers for Disease Control and Prevention would reevaluate the need for the testing requirement every 90 days and that it could be reinstated if a troubling new variant emerges.
COVID-19 vaccine makers are studying updated boosters that might be offered in the fall to better protect people against future coronavirus surges.
Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.
The declined money ranged from $177 for the one-person village of Monowi, Nebraska, to $3.9 million for DeWitt County, Texas, population about 20,000.
Americans might soon get a new COVID-19 vaccine option—shots made with a more tried-and-true technology than today’s versions.
The advance toward a vaccine for infants, toddlers and preschoolers has been an achingly slow and incremental process, with pediatricians and families waiting for an opportunity to vaccinate young children.
Administration officials say they’re running low on money to stock up on, or even begin to order, the latest vaccines, tests and treatments. Also lacking are funds to reimburse doctors treating uninsured patients and to help poor countries control the pandemic.
Despite a nationwide surge in COVID-19 cases, deaths from the virus have remained largely stable over the past eight weeks.
This week, the Centers for Disease Control and Prevention released new estimates of the syndrome’s toll in the United States, suggesting it affects one in five adults younger than 65 who had COVID, and one in four of those aged 65 and older.
Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest children get the shots. The 18 million tots under 5 make up the only group in the U.S. not yet eligible for COVID-19 vaccination.
